01061.HK
Essex Bio-Technology Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 2.27
+8.11%Margins
Gross margin
86.9%
EBITDA margin
23.3%
EBIT margin
18.4%
Net margin
15.4%
FCF margin
8.9%
10.4%
Return on equity
7.3%
Return on assets
11.0%
Return on invested capital
0.48x
Asset turnover
HKD 285.0M
Cash from operations
HKD 1.42
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026